Singh S
Comb Chem High Throughput Screen. 2023; 27(18):2623-2638.
PMID: 37861041
DOI: 10.2174/0113862073269599231009115338.
Ruggieri L, Moretti A, Berardi R, Cona M, Dalu D, Villa C
Int J Mol Sci. 2023; 24(5).
PMID: 36902406
PMC: 10002538.
DOI: 10.3390/ijms24054974.
Akkol E, Bardakci H, Barak T, Aschner M, Seker Karatoprak G, Khan H
Oxid Med Cell Longev. 2022; 2022:6044640.
PMID: 36017236
PMC: 9398845.
DOI: 10.1155/2022/6044640.
Shah H, Pang L, Qian S, Sathish V
NPJ Breast Cancer. 2021; 7(1):122.
PMID: 34535685
PMC: 8448825.
DOI: 10.1038/s41523-021-00330-9.
Choi J, Suh J, Kim D, Na H, Surh Y
J Cancer Prev. 2020; 25(3):152-163.
PMID: 33033709
PMC: 7523036.
DOI: 10.15430/JCP.2020.25.3.152.
Acidic Exopolysaccharide Produced from Marine 3MS 2017 for the Protection and Treatment of Breast Cancer.
Ibrahim A, Youness E, Mahmoud M, Asker M, El-Newary S
Breast Cancer (Auckl). 2020; 14:1178223420902075.
PMID: 32047357
PMC: 6984436.
DOI: 10.1177/1178223420902075.
Natural Products for the Management and Prevention of Breast Cancer.
Mitra S, Dash R
Evid Based Complement Alternat Med. 2018; 2018:8324696.
PMID: 29681985
PMC: 5846366.
DOI: 10.1155/2018/8324696.
Role of Aspirin in Breast Cancer Survival.
Chen W, Holmes M
Curr Oncol Rep. 2017; 19(7):48.
PMID: 28597105
DOI: 10.1007/s11912-017-0605-6.
Expression of cyclooxygenase-2 in cervical cancer is associated with lymphovascular invasion.
Hoellen F, Waldmann A, Banz-Jansen C, Rody A, Heide M, Koster F
Oncol Lett. 2016; 12(4):2351-2356.
PMID: 27698799
PMC: 5038214.
DOI: 10.3892/ol.2016.4925.
Prognostic significance of cyclooxygenase-2 expression in patients with hepatocellular carcinoma: a meta-analysis.
Chen G, Li X, Yang J, Li J, Wang X, He J
Arch Med Sci. 2016; 12(5):1110-1117.
PMID: 27695503
PMC: 5016591.
DOI: 10.5114/aoms.2016.61916.
High expression of TRIM44 is associated with enhanced cell proliferation, migration, invasion, and resistance to doxorubicin in hepatocellular carcinoma.
Zhu X, Wu Y, Miao X, Li C, Yin H, Yang S
Tumour Biol. 2016; 37(11):14615-14628.
PMID: 27619678
DOI: 10.1007/s13277-016-5316-3.
Association of EP2 receptor and SLC19A3 in regulating breast cancer metastasis.
Cheuk I, Shin V, Siu M, Tsang J, Ho J, Chen J
Am J Cancer Res. 2016; 5(11):3389-99.
PMID: 26807319
PMC: 4697685.
Cyclooxygenase-2 gene polymorphisms and the risk of colorectal cancer: A population-based study.
Li H, Guo Q, Zhou B, He S
Oncol Lett. 2015; 10(3):1863-1869.
PMID: 26622766
PMC: 4533694.
DOI: 10.3892/ol.2015.3477.
Pre-irradiation of mouse mammary gland stimulates cancer cell migration and development of lung metastases.
Bouchard G, Bouvette G, Therriault H, Bujold R, Saucier C, Paquette B
Br J Cancer. 2013; 109(7):1829-38.
PMID: 24002607
PMC: 3790160.
DOI: 10.1038/bjc.2013.502.
Role of LOXs and COX-2 on FAK activation and cell migration induced by linoleic acid in MDA-MB-231 breast cancer cells.
Serna-Marquez N, Villegas-Comonfort S, Galindo-Hernandez O, Navarro-Tito N, Millan A, Salazar E
Cell Oncol (Dordr). 2012; 36(1):65-77.
PMID: 23179791
DOI: 10.1007/s13402-012-0114-4.
Modulation of CXCR3 ligand secretion by prostaglandin E2 and cyclooxygenase inhibitors in human breast cancer.
Bronger H, Kraeft S, Schwarz-Boeger U, Cerny C, Stockel A, Avril S
Breast Cancer Res. 2012; 14(1):R30.
PMID: 22333315
PMC: 3496148.
DOI: 10.1186/bcr3115.
Prostaglandin E2 EP receptors as therapeutic targets in breast cancer.
Reader J, Holt D, Fulton A
Cancer Metastasis Rev. 2011; 30(3-4):449-63.
PMID: 22002714
PMC: 3640271.
DOI: 10.1007/s10555-011-9303-2.
Aspirin intake and survival after breast cancer.
Holmes M, Chen W, Li L, Hertzmark E, Spiegelman D, Hankinson S
J Clin Oncol. 2010; 28(9):1467-72.
PMID: 20159825
PMC: 2849768.
DOI: 10.1200/JCO.2009.22.7918.
Cyclooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrow.
Lucci A, Krishnamurthy S, Singh B, Bedrosian I, Meric-Bernstam F, Reuben J
Breast Cancer Res Treat. 2008; 117(1):61-8.
PMID: 18663571
PMC: 5842357.
DOI: 10.1007/s10549-008-0135-x.
Cyclooxygenase-2 inhibition: effects on tumour growth, cell cycling and lymphangiogenesis in a xenograft model of breast cancer.
Barnes N, Warnberg F, Farnie G, White D, Jiang W, Anderson E
Br J Cancer. 2007; 96(4):575-82.
PMID: 17285134
PMC: 2360050.
DOI: 10.1038/sj.bjc.6603593.